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Background Fetal macrosomia is associated with an increased risk
of adverse maternal and neonatal outcomes.
Objectives To compare the accuracy of antenatal two-dimensional
(2D) ultrasound, three-dimensional (3D) ultrasound, and
magnetic resonance imaging (MRI) in predicting fetal macrosomia
at birth.
Search strategy Medline (1966–2013), Embase, the Cochrane
Library and Web of Knowledge.
Selection criteria Cohort or diagnostic accuracy studies of women
with a singleton pregnancy, who had third-trimester imaging to
predict macrosomia (>4000 g, >4500 g or >90th or >95th
centile).
Data collection and analysis Two reviewers screened studies,
performed data extraction and assessed methodological quality.
The bivariate model was used to obtain summary sensitivities,
specificities and likelihood ratios.
Main results Fifty-eight studies (34 367 pregnant women) were
included. Most were poorly reported. Only one study assessed
3D ultrasound volumetry. For predicting birthweight >4000 g
or >90th centile, the summary sensitivity for 2D ultrasound
(Hadlock) estimated fetal weight (EFW) >90th centile or
>4000 g (29 studies) was 0.56 (95% CI 0.49–0.61), 2D
ultrasound abdominal circumference (AC) >35 cm (four
studies) was 0.80 (95% confidence interval [95% CI] 0.69–
0.87) and MRI EFW (three studies) was 0.93 (95% CI 0.76–
0.98). The summary specificities were 0.92 (95% CI 0.90–0.94),
0.86 (95% CI 0.74–0.93) and 0.95 (95% CI 0.92–0.97),
respectively.
Conclusion There is insufficient evidence to conclude that MRI
EFW is more sensitive than 2D ultrasound AC (which is more
sensitive than 2D EFW); although it was more specific. Further
primary research is required before recommending MRI EFW for
use in clinical practice.
Keywords Estimated fetal weight, macrosomia, magnetic
resonance imaging, pregnancy, three-dimensional ultrasound, two-
dimensional ultrasound.
Tweetable abstract Systematic review of antenatal imaging to
predict macrosomia. MRI EFW is more sensitive than ultrasound
EFW.
Linked article: This article has journal club questions by EYL
Leung, p. 89 in this issue. To view these visit http://dx.doi.org/
10.1111/1471-0528.13518.
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Introduction
Macrosomia occurs as a result of excessive intrauterine fetal
growth. A number of thresholds of birthweight have been
used to define macrosomia, including >4000 g, >4500 g,
>90th or >95th centile on a population nomogram.1,2
Macrosomia is associated with an increased risk of shoulder
dystocia and birth trauma, with associated adverse maternal
and neonatal outcomes. These include maternal postpar-
tum haemorrhage, third- and fourth-degree tears, and frac-
tures, Erb’s palsy and hypoxic injury to the infant.3 These
not only impact on the health of the individuals involved
but represent a significant cost to the NHS, both for long-
term care and settlement of litigation cases.4
Fetal macrosomia is associated with maternal diabetes mel-
litus (gestational or pre-existing) and obesity, both of which
are increasing in incidence.5 The risk of shoulder dystocia is
significantly higher in infants of mothers with diabetes.6
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Systematic review
Antenatal prediction of macrosomia is often inaccurate.7
A variety of ultrasound measurements have been used for
this purpose. A systematic review published in 2005
assessed the accuracy of two dimensional (2D) ultrasound
biometry for prediction of macrosomia, and found that
ultrasound was an overall poor predictor of fetal macroso-
mia, regardless of whether estimated fetal weight (EFW),
computed from measurements of fetal head circumference
(HC), abdominal circumference (AC) and femur length
(FL), or fetal AC alone, was used.8 As such, using ultra-
sound to assess the general antenatal population who are
felt to be large for dates on clinical assessment is not rec-
ommended.9
Since publication of this review, three-dimensional (3D)
ultrasound and magnetic resonance imaging (MRI) have
become increasingly used in the assessment of the fetus in
utero, and studies have examined their use in the estima-
tion of fetal weight.10,11 Therefore, the aim of this system-
atic review was to evaluate the predictive accuracy of 3D
ultrasound and MRI for macrosomia at birth; to update
the evidence on the accuracy of 2D ultrasound biometry;
and to compare the accuracy of the three modalities.
Method
A protocol-driven systematic review was performed in
accordance with published guidelines.12,13 The review was
registered with PROSPERO (CRD42013006127). The
protocol is available from http://www.crd.york.ac.uk/
PROSPERO/display_record.asp?ID=CRD42013006127. The
reporting of the review meets the criteria specified in the
PRISMA guidance.14
Literature search
We performed electronic searches from database inception
until December 2013. We searched MEDLINE (1966 to
December 2013), EMBASE (1980 to December 2013), the
Cochrane Library (issue 12, 2013), the British Nursing
Index (EBSCO) and MEDION, for relevant published
articles. In order to identify ‘grey’ literature, OpenGrey,
and Web of Science were also searched for relevant cita-
tions. In MEDLINE the search consisted of a combina-
tion of MESH headings (e.g. Pregnancy, Prenatal
Ultrasonography), keywords (e.g. biometry, volumetry)
and word variants using the Boelean operator ‘OR’ for
capturing citations of the relevant text. These were com-
bined using ‘AND’ with a combination of MESH head-
ings (e.g. Fetal Macrosomia), keywords (e.g. birthweight,
large for gestational age) and word variants to capture
relevant outcomes. No language restrictions were applied.
The MEDLINE search strategy is given in the Supplemen-
tary material (Appendix S1); this was adapted for use in
other databases. Hand searching of recent major journals
was also performed. A comprehensive database collating
all citations was constructed using REFERENCE MANAGER
12.0.
Study selection and data extraction
Initially, the database was scrutinised by two reviewers
(GJB and GLM, 50% in duplicate) and full articles of all
citations that were likely to meet the predefined selection
criteria were obtained. Articles in languages other than
English were translated. Following examination of full text
articles, final inclusion or exclusion decisions were made by
two reviewers (NWJ and GJB or GLM), adhering to the
following criteria:
1 Population: Women with a singleton pregnancy
2 Index test: 2D or 3D ultrasound scan or MRI performed
in the third trimester to detect fetal macrosomia. Several
formulae are used for calculating EFW based on a com-
bination of sonographic fetal measurements. Studies
were included irrespective of the formula and threshold
used to define macrosomia.
3 Reference standard (outcome): Birthweight >4000 g,
>4500 g, >90th or >95th centile.
4 Study design: Diagnostic accuracy or cohort studies that
allowed construction of 2 9 2 tables of the number of
true positives, false positives, false negatives and true
negatives. Studies with ten or fewer women were
excluded because such studies were likely to provide
unreliable estimates of test performance. Case–control
studies were excluded because of their tendency to exag-
gerate the magnitude of test accuracy.15,16
All manuscripts were carefully examined to identify over-
lapping populations. Where this was the case, the most
recent and complete manuscripts were selected. We applied
no language restriction in the selection of studies. The ref-
erence lists of selected studies and review articles were
checked and additional relevant articles were obtained.
Data extraction was performed using a data collection sheet
and was done in duplicate (NWJ and GJB or GLM). Data
were extracted on study characteristics (including threshold
values used), quality assessment criteria and test accuracy
estimates, and were entered into an EXCEL spreadsheet. If
results for multiple thresholds were reported, we con-
structed a separate 2 9 2 table for each threshold. In stud-
ies where data were felt to be relevant but 2 9 2 tables
could not be constructed, we attempted to contact the
authors. Disagreements between reviewers in the selection
of studies and data extraction were resolved by consulting
a third reviewer.
Quality assessment
The included studies were assessed for methodological
quality using the QUADAS-2 checklist.17 The checklist con-
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sists of four domains: patient selection, index test, reference
standard and flow and timing. Based on a number of sig-
nalling questions, each of the four domains are assessed for
risk of bias but only the first three domains are assessed for
applicability concerns. Patient selection was considered to
have a high risk of bias if anything other than a consecu-
tively or randomly recruited study population was
reported. If the threshold of the index test used to predict
macrosomia was not prespecified, a high risk of bias was
reported. We defined an appropriate interval between the
index test (antenatal scan) and reference standard (birth-
weight) as <7 days. If the time lapse was greater, we
assigned a high risk of bias in the ‘flow and timing’
domain. Where studies were inadequately reported, making
it not possible to make a clear judgement about risk of bias
or applicability concern, the category was assigned an
‘unclear risk’ or ‘unclear concern’. We planned to perform
sensitivity analyses where possible by excluding studies at
‘high or unclear risk of bias’ in a domain.
Data synthesis
To assess the diagnostic accuracy of a test, we used the
2 9 2 tables to calculate sensitivity, specificity, positive and
negative likelihood ratios, and their 95% confidence inter-
vals (CI). We plotted estimates of sensitivity and specificity
in receiver operating characteristic space and on forest
plots to explore between study differences in estimates of
test performance.
For studies that used the same index test and reference
standard at the same threshold, we performed meta-analy-
sis using the bivariate model to jointly synthesise sensitivity
and specificity.18,19 The bivariate model includes random
effects that allow for between-study variation in sensitivity
and specificity, as well as a correlation parameter that
allows for the trade-off in sensitivity and specificity across
studies. We used parameter estimates from the model to
derive likelihood ratios with their 95% confidence inter-
vals.20 Given the complexity of the bivariate model, where
few studies were available, we simplified the model by
removing the correlation parameter or assuming fixed
effects for sensitivity and/or specificity. We included studies
that defined macrosomia using either birthweight >90th
centile or >4000 g in the same meta-analysis because both
are generally considered to be similar. However, we also
performed subgroup analyses considering each definition
independently.
To compare the accuracy of the tests, we added a
covariate for test type to the bivariate model to assess its
effect on sensitivity and specificity. The statistical signifi-
cance of the difference in test performance was assessed
using a likelihood ratio test comparing models with and
without the covariate terms. We investigated the type of
population (high risk versus low risk) as a potential
source of heterogeneity by adding a covariate to the
bivariate model. We classified a study population as high
risk if the women in question had a higher risk of fetal
macrosomia than the general obstetric population, includ-
ing pre-existing or gestational diabetes, obesity or post-
maturity (>40 weeks of gestation). Low risk was classified
as women without these conditions, or an unselected
obstetric population.
Determinants of publication bias are not well understood
for test accuracy studies. Commonly used methods for
assessing publication bias are not appropriate for test accu-
racy reviews.18 We planned to use the recommended
approach of Deeks et al.21 if there was minimal heterogene-
ity because like all other approaches, this approach has low
power for detecting funnel plot asymmetry when there is
heterogeneity.21 All analyses were performed in STATA
version 13.0 (StataCorp, College Station, TX, USA) and
meta-analyses were performed using the STATA xtmelogit
command. We used REVIEW MANAGER (version 5.3; Copen-
hagen; The Nordic Cochrane Center, The Cochrane Collab-
oration, 2014) to generate forest plots and summary
receiver operating characteristic plots.
Results
We identified 4140 citations, of which 459 were considered
for full text review. Of these, 401 articles were excluded for
reasons shown in Figure 1. Fifty-eight studies involving
34 367 pregnant women were included.10,11,22–77 The char-
acteristics of included studies are given in the Supplemen-
tary material (Table S1). The majority of studies (97%)
reported 2D ultrasound parameters, with only one study
providing data on the accuracy of 3D ultrasound volume-
try. There were five studies with data on antenatal MRI
volumetry. One of these was performed in our centre.51 Of
the remaining four studies, two used the same study popu-
lation.11,78 We therefore included only the most complete
data set.11 Of the remaining two studies, one contained
fewer than five women and was therefore excluded.79 There
were concerns that the population in the second study did
not meet our inclusion criteria as women undergoing ter-
mination of pregnancy at >20 weeks of gestation were also
included, and scans were not restricted to the third trime-
ster as we prespecified.46 We attempted to contact the
authors to obtain the relevant data, but received no
response. As there was paucity of data on MRI, we
included this study, which compared MRI and 2D ultra-
sound in the same women with the intention of perform-
ing a sensitivity analysis excluding the study.
Quality assessment
Methodological quality varied between studies but risk of
bias was generally unclear because of poor reporting. The
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summary of the quality assessment of the included studies
is shown in Figure 2. None of the studies was scored as
low risk of bias in all domains. Two studies22,63 were
scored as either high or unclear risk of bias in all four
domains. Most of the studies were scored as unclear risk of
bias in the patient selection domain (76%) and reference
standard domain (95%). In contrast, most of the studies
were scored as low risk of bias in the index test domain
(79%). In the flow and timing domain, 45% of studies
were scored as high risk of bias. As most studies were
scored high or unclear risk of bias in all domains except
the index test domain, we did not perform sensitivity anal-
yses. Most studies (79%) had low concern regarding appli-
cability across all three domains. One study46 that gave
particular concern regarding applicability has been
described above.
Accuracy of 2D ultrasound parameters for
predicting fetal macrosomia
Thirty-one studies estimated fetal weight using any Had-
lock formula at a threshold of EFW >90th centile or
>4000 g to predict birthweight defined at the same thresh-
olds. Two study populations24,56 were duplicated and were
therefore excluded from the meta-analysis of studies using
Citations identified from electronic searches 
(Database inception to December 2013)  n = 4140
Potentially relevant articles obtained in full manuscripts 
n = 459
Identified from electronic searches n = 452
Identified from manual checking n = 7
Articles excluded from review with reasons:
Incorrect index test n = 182
Inappropriate outcome measure n = 7
Lack of original data (review articles/letters)    n = 81
Duplicate publications                                        n = 6
Incorrect study design/ size n = 13
Incorrect population n = 26 
Accuracy data not extractable                        n = 71
Papers unavailable                                                   n = 15
Total excluded                                                n = 401
Citations excluded n = 3688
Selected for inclusion n = 58   (34 367 women)
Index test                                                    No. of studies     No. of women
Magnetic resonance imaging estimated fetal weight (Baker) 3 299
3D Ultrasound EFW (Schild) > 4000 g 1 200
2D Ultrasound EFW (Hadlock) > 90th centile/4000 g 29 14 762
2D Ultrasound EFW (Hadlock) other thresholds 4 5570
2D Ultrasound EFW (Hadlock) + other parameters 4 2541
2D Ultrasound EFW (Shepard) >4000 g 5 1035
2D Ultrasound EFW (other formulae) 7 5901
2D Ultrasound AC >90th centile 5 1063
2D Ultrasound AC >35 cm 4 1831
2D Ultrasound AC (other thresholds) 8 4889
2D Ultrasound - other parameters 3 438
15 studies reported more than one index test
Figure 1. Study selection process for systematic review of the diagnostic accuracy of antenatal ultrasound and MRI scan for fetal macrosomia at
birth.
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either EFW >90th centile or >4000 g, but were included in
the subgroup analyses that considered EFW >90th centile
and EFW >4000 g separately. The sensitivities from the 29
studies (2085 cases, 14 762 women) ranged between 0.13
and 1.00, and the specificities ranged between 0.66 and
0.99 (see Supplementary material, Figure S1). The median
pretest probability (prevalence) of fetal macrosomia, calcu-
lated using the 29 studies, was 11% (interquartile range
19–26%). Substantial heterogeneity was observed as shown
by the extent of the 95% prediction region around the
summary point on the summary receiver operating charac-
teristic plot (Figure 3), The summary sensitivity and speci-
ficity of 2D ultrasound EFW were 0.56 (95% CI 0.49–0.61)
and 0.92 (95% CI 0.90–0.94), respectively (Table 1). The
summary positive and negative likelihood ratios were 7.2
(5.5–9.4) and 0.48 (0.42–0.55).
Results obtained from the subgroup analyses of EFW
>90th centile to predict birthweight >90th centile, and
EFW >4000 g to predict birthweight >4000 g were similar
to those from the combined analysis (see Supplementary
material, Table S2). A sensitivity analysis excluding the
study by Kacem et al.46 also did not change the result. A
sensitivity analysis including only the five stud-
ies43,49,59,62,73 that used any Hadlock formula incorporating
HC, AC and FL to compute estimated fetal weight gave
similar results to the analysis that included studies using
any version of the Hadlock formula. Investigation of type
of population as a potential source of heterogeneity
showed no evidence of a difference in sensitivity (P = 0.9)
and specificity (P = 0.4) between low-risk and high-risk
populations (see Supplementary material, Table S3). We
did not assess publication bias because of the observed
heterogeneity.
Estimates of sensitivity and specificity from studies that
used the Hadlock formula at other thresholds, the Had-
lock formula plus other parameters, or other EFW formu-
lae are given in Figure S2 (see Supplementary material).
For AC >35 cm (four studies), the summary sensitivity
and specificity were 0.80 (95% CI 0.69–0.87) and 0.86
(95% CI 0.74–0.93), respectively. Figure S3 (see Supple-
mentary material) shows the estimates of sensitivity and
specificity for studies that used other AC thresholds. Fig-
ure S4 (see Supplementary material) shows the estimates
for studies that used other 2D ultrasound parameters.
Where meta-analyses were possible, the summary estimates
obtained are presented in Table 1. The summary sensitiv-
ity and specificity of 2D ultrasound using the Shepard for-
mula were similar to the summary estimates for the
Hadlock formula.
Figure 2. Summary of methodological quality assessment of risk of bias and applicability concerns presented for each domain as percentages across
all included studies. The numbers on the bar for each domain represents the number of studies that were scored as high, unclear or low risk of bias
or applicability concern.
Figure 3. Summary receiver operating characteristic plot of MRI, 2D
ultrasound EFW using any Hadlock formula at threshold EFW >90th
centile or >4000 g, and AC >35 cm for prediction of macrosomia. The
symbol for each test represents the pair of sensitivity and specificity
from a study. The symbols are scaled according to sample size. The
solid circles represent the summary sensitivity and specificity for each
test. The summary points are surrounded by 95% confidence regions
(dotted line) and 95% prediction regions (dashed line).
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Accuracy of 3D ultrasound for predicting fetal
macrosomia
Only one study10 reported the accuracy of 3D ultrasound
volumetry EFW to predict birthweight >4000 g (see Sup-
plementary material, Figure S1). The sensitivity was 0.42
(95% CI 0.26–0.61) and specificity was 0.98 (95% CI 0.95–
1.00).
Accuracy of MRI for predicting fetal macrosomia
Three studies (41 cases, 299 women) using fetal volumes and
the formula reported by Baker et al.80 to estimate fetal
weight were included in the meta-analysis (Figure 3, and see
Supplementary material, Figure S1). The median pretest
probability (prevalence) of fetal macrosomia was 11% (range
17–18%). Two studies used a threshold of >4000 g, and one
used >90th centile. The summary sensitivity of MRI was
0.93 (95% CI 0.76–0.98) and summary specificity was 0.95
(95% CI 0.92–0.97). The positive and negative likelihood
ratios were 20.0 (95% CI 9.6–41.7) and 0.07 (95% CI 0.02–
0.28). When we excluded the study that did not match our
inclusion criteria exactly, the sensitivity was 0.85 (95% CI
0.62–0.95) and specificity was 0.97 (95% CI 0.90–0.99).
Comparison of the accuracy of 2D ultrasound and
MRI
Based on 34 studies, there was a significant difference
(P = 0.0002) in the performance of MRI (three studies),
2D ultrasound (Hadlock) EFW (29 studies), and AC
>35 cm (four studies) for predicting macrosomia. The sen-
sitivity of MRI was significantly superior to that of 2D
ultrasound EFW (P = 0.001), and despite a 13% difference
in sensitivity between MRI and AC >35 cm, the difference
was not statistically significant (P = 0.12). The specificity
of MRI was significantly higher than that of 2D ultrasound
AC >35 cm (P = 0.02) but there was no evidence of a dif-
ference in specificity between MRI and 2D ultrasound
EFW (P = 0.11). 2D ultrasound AC >35 cm was more sen-
sitive than 2D ultrasound EFW (P = 0.003), but less speci-
fic (P = 0.012).
There were no studies that compared 2D ultrasound AC
and MRI in the same population. The findings of the com-
parison of meta-analyses between 2D ultrasound EFW and
MRI EFW were consistent with the findings of the two
studies that compared these tests in the same population.
Zaretsky et al.11 found that 2D ultrasound (Hadlock) EFW
>4000 g had a sensitivity of 0.35 (95% CI 0.13–0.65) and
specificity of 0.97 (95% CI 0.89–1.00) compared with MRI
EFW >4000 g with a sensitivity of 0.86 (95% CI 0.57–0.98)
and specificity of 0.97 (95% CI 0.89–1.00).
Kacem et al.46 found that ultrasound EFW (Hadlock)
>4000 g had sensitivity of 0.81 (95% CI 0.58–0.95) and
specificity of 0.90 (95% CI 0.85–0.94), while MRI EFW
>4000 g had sensitivity of 1.00 (95% CI 0.84–1.00) and
specificity of 0.95 (95% CI 0.90–0.98).
For illustration purposes, given a pretest probability of
17% (median from the 34 studies), the findings imply that
in a hypothetical cohort of 1000 pregnant women, 170
babies will be born with birthweight >90th centile or
>4000 g. Of the 170 macrosomic babies, 2D ultrasound
EFW will miss 75, AC >35 cm will miss 34 while MRI will
only miss 12 babies. Of the 830 babies without macroso-
mia, 2D ultrasound EFW will incorrectly identify 66 and
AC will incorrectly identify 116 as macrosomic whereas
MRI EFW will incorrectly identify 42 babies as macro-
somic. Using the likelihood ratios and the same pretest
probability, the post-test probability of having macrosomia
is 9.0 and 4.7% for a negative test result for 2D ultrasound
EFW and AC >35 cm respectively, and 60 and 54% for a
positive test result. However, the post-test probability of
having macrosomia is 1.4% if MRI EFW is negative and
80% if MRI EFW is positive for macrosomia.
Discussion
Main findings
The majority of studies reported 2D ultrasound EFW, cal-
culated with any Hadlock formula, for a birthweight
threshold of >4000 g or >90th centile. Our results show
that this test has reasonable specificity (i.e. low false-posi-
tive rate) but poor sensitivity (high false-negative rate). The
likelihood ratios indicate that a positive result may rule in
macrosomia, but a negative result does not rule it out. The
Perinatal Institute recommend using a Hadlock formula
including HC, AC and FL for estimating fetal weight.81
When we performed sensitivity analysis limited to studies
using the same parameters and citing the same reference82
the results were similar.
MRI volumetry to estimate fetal weight appeared to be
much more sensitive than 2D ultrasound EFW for predict-
ing fetal macrosomia. However, these results were based on
few studies and small numbers.
Strengths and limitations
The strength of our review and the validity of our infer-
ences lie in the methodology and the volume of evidence.
We have complied with existing guidelines for conducting13
and reporting systematic reviews.14 We have used recom-
mended techniques for performing and interpreting meta-
analysis.19,83 An extensive literature search was performed
without language restrictions.
There are several limitations to our review. Despite
extensive searches, there was a paucity of data on 3D ultra-
sound. Only one study was identified where data could be
extracted to populate a 2 9 2 table. Six other studies were
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identified through our searches.84–89 However, none of
them looked specifically at using 3D ultrasound to predict
macrosomia, and often included small numbers of macro-
somic infants. When a comparison of 2D and 3D ultra-
sound was made for general fetal weight estimation, one
study found that combining fetal thigh volume with 2D
biometry gave a higher proportion of estimated weights
within 5% of actual birthweight than 2D ultrasound using
the Hadlock formula alone (70 versus 40%).89 However,
three other studies found no difference in the accuracy of
weight estimation between 2D and 3D ultrasound.84–89
Only three MRI studies were included. One of these did
not strictly meet our inclusion criteria.46 We explored the
impact of including this study by performing a sensitivity
analysis. Excluding the study did not affect the summary
estimates for 2D ultrasound EFW, but the summary sensi-
tivity of MRI was reduced. However, the sensitivity of MRI
for predicting fetal macrosomia was still greater than that
of ultrasound, and we are confident that our conclusions
are valid.
Differences may exist between the study populations that
were combined in the meta-analyses, and the techniques
used for the index tests and reference standard may have
differed. There are several different formulae reported by
Hadlock in calculating estimated fetal weight.82,90–93 It was
not always possible to determine from the primary reports
exactly which formula was used. Although all studies cited
a reference, multiple formulae were reported in Hadlock’s
original reports. This may result in some variability within
the meta-analysis groups including ‘any’ Hadlock formula,
because variations in accuracy between these formulae have
been reported.59,61 In order to address this, we performed a
sensitivity analysis including only studies that cited the for-
mula considered to be the most accurate. The results were
comparable with the overall analysis.
Another limitation of this review is that by only analys-
ing sensitivity and specificity according to prespecified
thresholds of birthweight, we did not assess the mean
absolute error of the individual techniques for birthweight
as a continuous variable. We were limited by the data
reported in the primary studies, which tended to report
outcomes according to prespecified thresholds. Individual
patient data meta-analysis could be performed to address
this, but was considered beyond the scope of the current
project.
A comparison of the accuracy of different tests using
studies that have not compared the tests in the same study
population may be prone to confounding.94 However, only
two studies compared MRI and 2D ultrasound EFW in the
same population. The individual study results were consis-
tent with the findings of the meta-analysis that used all
available studies to compare both tests.
Comparison with other studies
We are not aware of any other systematic reviews examin-
ing the accuracy of antenatal MRI or 3D ultrasound for
macrosomia at birth. For 2D ultrasound EFW, our results
were similar to those published by Coomarasamy et al. in
2005.8 They concluded that there was a lack of precision in
2D ultrasound in the prediction of fetal macrosomia, and
that a positive test was more accurate for ruling in macro-
somia, than a negative test was for ruling it out.8 We iden-
tified and included a number of studies (with larger
numbers of women) published subsequent to this review.
We found that AC >35 cm appeared to be more sensitive
that ultrasound EFW >90th or 4000 g, but less specific,
and therefore overall a poor predictive test. Our results also
agree with the findings of the NICE Antenatal Care guide-
line.9
Implications for clinical practice
MRI appears to show promise as an accurate antenatal test
for predicting fetal macrosomia at birth. This has the
potential to improve care for both women at high risk of
macrosomia (including those with diabetes and obesity)
and low-risk women. MRI is becoming increasingly avail-
able and is known to be safe in pregnancy, making its use
for estimating fetal weight a realistic prospect. However,
there are several considerations before MRI can be used for
this purpose. This meta-analysis included very few studies
with small numbers of women receiving MRI compared
with evaluations of ultrasound. Therefore, there is still
uncertainty regarding the accuracy of MRI, and further
research is required before it can be considered for clinical
practice. The cost and feasibility of performing MRI on a
large scale must also be considered. There is a potential
role for using AC as a screening test to determine which
women should undergo fetal MRI EFW.
Recommendations
Further research is required, comparing MRI with 2D and
3D ultrasound in the same population. Given the findings
in our study that 2D ultrasound AC >35 cm appeared to
have a higher sensitivity (i.e. low false negative rate) than
2D ultrasound EFW a diagnostic strategy worthy of explo-
ration is a two-stage approach using AC >35 cm to screen
women. Those that screen positive would go on to have an
MRI. If the accuracy of this approach is proven to be com-
parable to that of MRI alone, this approach is likely to be
cheaper and more feasible, therefore applicable to a wider
antenatal population.
The other uncertainty regarding clinical practice in this
field is not only how best to predict fetal weight antena-
tally, but also how that information should be used. While
macrosomia, defined according to the thresholds used in
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this review, has been associated with adverse outcomes, a
large number of macrosomic babies deliver without prob-
lems, and shoulder dystocia and trauma occur where babies
are average weight.95 Although this review did not consider
labour outcomes, these must be considered in the evalua-
tion of diagnosis–treatment pathways involving MRI esti-
mated fetal weight, and whether early induction of labour
or caesarean section is cost-effective in reducing adverse
outcomes.
Conclusion
Using antenatal MRI to estimate fetal weight shows
promising accuracy for the prediction of macrosomia at
birth. However, further research is required before this
technique can be applied in clinical practice.
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